Fluvoxamine

cytochrome P450 family 2 subfamily C member 9 ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32802593 Lithium Intoxication in the Elderly: A Possible Interaction between Azilsartan, Fluvoxamine, and Lithium. 2020 Apr 1 1
2 30620511 [The Drug Interaction that Psychiatrists Should be Careful about]. 2016 1
3 21277363 Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes. 2011 Apr 10 1
4 17307149 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. 2007 Apr 6 1
5 15199661 Some aspects of genetic polymorphism in the biotransformation of antidepressants. 2004 Jan-Feb 1
6 11876575 Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. 2002 Feb 1
7 12452751 Fluvoxamine interaction with warfarin. 2002 Dec 1
8 11180037 Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. 2001 Jan 3
9 11206048 Phenytoin intoxication induced by fluvoxamine. 2001 Feb 1
10 10192756 Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes. 1999 Feb 1
11 10627170 CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor. 1999 Dec 1
12 9384467 Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation. 1997 Nov 1